Tag: Therapy & Procedures: Misc.
Tumor-Infiltrating Lymphocytes Up PFS in Advanced Melanoma
Significantly longer progression-free survival seen with infusion of tumor-infiltrating lymphocytes versus ipilimumab
FDA: No Useful Monoclonal Antibody Treatments Left Against New COVID-19 Variants
Immunocompromised patients can still receive convalescent plasma
Treatment Without ADT Delays Initiation of Systemic Therapy in Prostate Cancer
Metastasis-directed therapy can delay initiation of systemic therapy in patients with solitary oligorecurrent metastatic lesion
Adverse Events Mild, Rare With mAb Treatment for COVID-19 in Pregnancy
No differences seen in any obstetric-associated outcome or in composite 28-day COVID-19 outcome
Higher Tisagenlecleucel Doses May Improve Outcomes in Youth With B-ALL
Overall, event-free, relapse-free survival improved in patients receiving higher doses of tisagenlecleucel, with no increased toxicity
Marketing of Shockwave Therapy for Erectile Dysfunction Raises Concerns
Techniques, costs, and provider credentials in biggest U.S. cities vary widely
ACC: Lasting Reduction in BP Seen With Radiofrequency Renal Denervation
Significant reductions in systolic and diastolic BP observed at up to 36 months following intervention versus sham control procedure
Early Use of COVID-19 Convalescent Plasma Cuts Hospitalization Risk
Administration of convalescent plasma within nine days after symptom onset can reduce risk of COVID-19-linked hospitalization
Gene Therapy Potentially Curative for β-Thalassemia
Transfusion independence, near-normal Hb levels seen for most children and adults receiving beti-cel for non-β0/β0 genotype β-thalassemia
Enhanced External Counterpulsation Eases ‘Long COVID’
Improvements seen in symptoms of fatigue, breathing difficulties, 6-minute walk test with EECP treatment
